Exact Mass: 679.3653

Exact Mass Matches: 679.3653

Found 124 metabolites which its exact mass value is equals to given mass value 679.3653, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Telaprevir

(3S)-3-{[(1S,3aR,6aS)-2-[(2S)-2-[(2S)-2-cyclohexyl-2-(pyrazin-2-ylformamido)acetamido]-3,3-dimethylbutanoyl]-octahydrocyclopenta[c]pyrrol-1-yl]formamido}-N-cyclopropyl-2-oxohexanamide

C36H53N7O6 (679.4057)


Telaprevir (VX-950) is a highly selective and potent inhibitor of the HCV NS3-4A serine protease. It is a member of a class of antiviral drugs known as protease inhibitors and is the first hepatitis C drug that has demonstrated activity in patients who have failed prior therapy. On April 28, 2011, the FDA Antiviral Drugs Advisory Committee voted 18-0 to recommend approval telaprevir for people with genotype 1 chronic hepatitis C and was approved in the U.S. in May, 2011. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AP - Antivirals for treatment of hcv infections C254 - Anti-Infective Agent > C281 - Antiviral Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

Nodulisporic acid

5-[7,24-dihydroxy-3,4,8,20,20,22,22-heptamethyl-27-oxo-28-(prop-1-en-2-yl)-21-oxa-1-azaoctacyclo[13.13.1.0²,¹⁴.0³,¹².0⁴,⁹.0¹⁷,²⁵.0¹⁸,²³.0²⁶,²⁹]nonacosa-2(14),15,17(25),18,26(29)-pentaen-8-yl]-2-methylpenta-2,4-dienoic acid

C43H53NO6 (679.3873)


   

Thymin

3-({6-amino-2-[(2-amino-5-carbamimidamido-1-hydroxypentylidene)amino]-1-hydroxyhexylidene}amino)-3-[(1-{[1-carboxy-2-(4-hydroxyphenyl)ethyl]-C-hydroxycarbonimidoyl}-2-methylpropyl)-C-hydroxycarbonimidoyl]propanoate

C30H49N9O9 (679.3653)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D007155 - Immunologic Factors

   

Difelikefalin

N-((2R)-1-(((2R)-1-(((2R)-6-Amino-1-(4-amino-4-carboxy-1-piperidinyl)-1-oxo-2-hexanyl)amino)-4-methyl-1-oxo-2-pentanyl)amino)-1-oxo-3-phenyl-2-propanyl)-D-phenylalaninamide

C36H53N7O6 (679.4057)


V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist Difelikefalin (CR-845; FE-202845) is a peripherally restricted and selective agonist of kappa opioid receptor (KOR). Difelikefalin produces anti-inflammatory effects and has the potential in modulating pruritus in conditions such as chronic kidney disease[1][2].

   

Nodulisporic acid A

(+)-Nodulisporic acid A

C43H53NO6 (679.3873)


   
   

Thiazinotrienomycin G

Thiazinotrienomycin G

C37H49N3O7S (679.3291)


   
   

1-(N-methyl-L-phenylalanyl)-L-proline (4S)-7t-benzyl-3t-isopropyl-5,8-dioxo-2-oxa-6,9-diaza-1(1,4)-benzena-cycloundecaphan-10c-en-4r-ylamide|N-demethyl-scutianine-A|Scutianin F|scutianine-F

1-(N-methyl-L-phenylalanyl)-L-proline (4S)-7t-benzyl-3t-isopropyl-5,8-dioxo-2-oxa-6,9-diaza-1(1,4)-benzena-cycloundecaphan-10c-en-4r-ylamide|N-demethyl-scutianine-A|Scutianin F|scutianine-F

C40H49N5O5 (679.3734)


   

Me ester-Pimaricin

Me ester-Pimaricin

C34H49NO13 (679.3204)


   

Gln Arg Val Met Phe

Gln Arg Val Met Phe

C30H49N9O7S (679.3475)


   

His Ala Tyr Tyr Leu

His Ala Tyr Tyr Leu

C34H45N7O8 (679.3329)


   

Telaprevir (VX-950)

Telaprevir (VX-950)

C36H53N7O6 (679.4057)


   

Arg Arg Trp Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C32H45N11O6 (679.3554)


   

Arg Arg Tyr Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C32H45N11O6 (679.3554)


   

Arg Trp Arg Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanoic acid

C32H45N11O6 (679.3554)


   

Arg Trp Tyr Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanoic acid

C32H45N11O6 (679.3554)


   

Arg Tyr Arg Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanoic acid

C32H45N11O6 (679.3554)


   

Arg Tyr Trp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoic acid

C32H45N11O6 (679.3554)


   

Trp Arg Arg Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanoic acid

C32H45N11O6 (679.3554)


   

Trp Arg Tyr Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanoic acid

C32H45N11O6 (679.3554)


   

Trp Tyr Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C32H45N11O6 (679.3554)


   

Tyr Arg Arg Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanoic acid

C32H45N11O6 (679.3554)


   

Tyr Arg Trp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-5-carbamimidamidopentanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanoic acid

C32H45N11O6 (679.3554)


   

Tyr Trp Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C32H45N11O6 (679.3554)


   

QRVMF

Gln-Arg-Val-Met-Phe

C30H49N9O7S (679.3475)


   

Telaprevir

(3S)-3-{[(1S,3aR,6aS)-2-[(2S)-2-[(2S)-2-cyclohexyl-2-(pyrazin-2-ylformamido)acetamido]-3,3-dimethylbutanoyl]-octahydrocyclopenta[c]pyrrol-1-yl]formamido}-N-cyclopropyl-2-oxohexanamide

C36H53N7O6 (679.4057)


J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AP - Antivirals for treatment of hcv infections C254 - Anti-Infective Agent > C281 - Antiviral Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

PHDdiA-PE

1-hexadecanoyl-2-(9-hydroxy-11-carboxy-10E-undecenoyl)-sn-glycero-3-phosphoethanolamine

C33H62NO11P (679.406)


   

OHHdiA-PS

1-(9Z-octadecenoyl)-2-(4-hydroxy-6-carboxy-5E-hexenoyl)-sn-glycero-3-phosphoserine

C31H54NO13P (679.3333)


   

Thymopentin

Thymopentin

C30H49N9O9 (679.3653)


L - Antineoplastic and immunomodulating agents > L03 - Immunostimulants > L03A - Immunostimulants D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D007155 - Immunologic Factors Thymopentin is a biologically active peptide secreted mainly by the epithelial cells of thymic cortex and medulla. Thymopentin is an effective immunomodulatory agent with a short plasma half-life of 30 seconds. Thymopentin enhances the generation of T-cell lineage derived from human embryonic stem cells (hESCs)[1][2]. Thymopentin is a biologically active peptide secreted mainly by the epithelial cells of thymic cortex and medulla. Thymopentin is an effective immunomodulatory agent with a short plasma half-life of 30 seconds. Thymopentin enhances the generation of T-cell lineage derived from human embryonic stem cells (hESCs)[1][2]. Thymopentin is a biologically active peptide secreted mainly by the epithelial cells of thymic cortex and medulla. Thymopentin is an effective immunomodulatory agent with a short plasma half-life of 30 seconds. Thymopentin enhances the generation of T-cell lineage derived from human embryonic stem cells (hESCs)[1][2].

   

Thymopentine

Thymopentine

C30H49N9O9 (679.3653)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones C308 - Immunotherapeutic Agent > C2139 - Immunostimulant D007155 - Immunologic Factors

   

Difelikefalin

Difelikefalin

C36H53N7O6 (679.4057)


V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist Difelikefalin (CR-845; FE-202845) is a peripherally restricted and selective agonist of kappa opioid receptor (KOR). Difelikefalin produces anti-inflammatory effects and has the potential in modulating pruritus in conditions such as chronic kidney disease[1][2].

   

(2E,4Z)-5-(7,24-dihydroxy-3,4,8,20,20,22,22-heptamethyl-27-oxo-28-prop-1-en-2-yl-21-oxa-1-azaoctacyclo[13.13.1.02,14.03,12.04,9.017,25.018,23.026,29]nonacosa-2(14),15,17(25),18,26(29)-pentaen-8-yl)-2-methylpenta-2,4-dienoic acid

(2E,4Z)-5-(7,24-dihydroxy-3,4,8,20,20,22,22-heptamethyl-27-oxo-28-prop-1-en-2-yl-21-oxa-1-azaoctacyclo[13.13.1.02,14.03,12.04,9.017,25.018,23.026,29]nonacosa-2(14),15,17(25),18,26(29)-pentaen-8-yl)-2-methylpenta-2,4-dienoic acid

C43H53NO6 (679.3873)


   

1-[[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea

1-[[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea

C34H48F3N5O6 (679.3557)


   

1-[[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea

1-[[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-16-[[oxo-(propan-2-ylamino)methyl]amino]-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-9-yl]methyl]-1-methyl-3-[4-(trifluoromethyl)phenyl]urea

C34H48F3N5O6 (679.3557)


   

5-methoxycarbonylpentyl 4,6-dideoxy-4-formamido-2-O-methyl-alpha-D-mannopyranosyl-(1->2)-4,6-dideoxy-4-formamido-alpha-D-mannopyranosyl-(1->3)-4,6-dideoxy-4-formamido-alpha-D-mannopyranoside

5-methoxycarbonylpentyl 4,6-dideoxy-4-formamido-2-O-methyl-alpha-D-mannopyranosyl-(1->2)-4,6-dideoxy-4-formamido-alpha-D-mannopyranosyl-(1->3)-4,6-dideoxy-4-formamido-alpha-D-mannopyranoside

C29H49N3O15 (679.3164)


   

(3R,3aS,6aR)-2-[(2S)-2-[[(2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide

(3R,3aS,6aR)-2-[(2S)-2-[[(2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide

C36H53N7O6 (679.4057)


   
   
   
   
   
   
   

SHexCer 10:1;2O/16:2;O

SHexCer 10:1;2O/16:2;O

C32H57NO12S (679.3601)


   

SHexCer 13:2;2O/13:1;O

SHexCer 13:2;2O/13:1;O

C32H57NO12S (679.3601)


   

SHexCer 12:2;2O/14:1;O

SHexCer 12:2;2O/14:1;O

C32H57NO12S (679.3601)


   

SHexCer 14:3;2O/12:0;O

SHexCer 14:3;2O/12:0;O

C32H57NO12S (679.3601)


   

SHexCer 14:2;2O/12:1;O

SHexCer 14:2;2O/12:1;O

C32H57NO12S (679.3601)


   

PI-Cer 12:2;2O/14:1;O

PI-Cer 12:2;2O/14:1;O

C32H58NO12P (679.3696)


   

PI-Cer 13:2;2O/13:1;O

PI-Cer 13:2;2O/13:1;O

C32H58NO12P (679.3696)


   

PI-Cer 14:2;2O/12:1;O

PI-Cer 14:2;2O/12:1;O

C32H58NO12P (679.3696)


   

PI-Cer 14:3;2O/12:0;O

PI-Cer 14:3;2O/12:0;O

C32H58NO12P (679.3696)


   
   

SHexCer 15:1;2O/12:1

SHexCer 15:1;2O/12:1

C33H61NO11S (679.3965)


   

(Z)-N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctan-2-yl]tridec-9-enamide

(Z)-N-[1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctan-2-yl]tridec-9-enamide

C33H61NO13 (679.4143)


   

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetradec-4-en-2-yl]heptanamide

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytetradec-4-en-2-yl]heptanamide

C33H61NO13 (679.4143)


   

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctadec-4-en-2-yl]propanamide

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctadec-4-en-2-yl]propanamide

C33H61NO13 (679.4143)


   

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoct-4-en-2-yl]tridecanamide

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoct-4-en-2-yl]tridecanamide

C33H61NO13 (679.4143)


   

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydodec-4-en-2-yl]nonanamide

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydodec-4-en-2-yl]nonanamide

C33H61NO13 (679.4143)


   

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydec-4-en-2-yl]undecanamide

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxydec-4-en-2-yl]undecanamide

C33H61NO13 (679.4143)


   

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxynon-4-en-2-yl]dodecanamide

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxynon-4-en-2-yl]dodecanamide

C33H61NO13 (679.4143)


   

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadec-4-en-2-yl]pentanamide

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyhexadec-4-en-2-yl]pentanamide

C33H61NO13 (679.4143)


   

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxynonadec-4-en-2-yl]acetamide

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxynonadec-4-en-2-yl]acetamide

C33H61NO13 (679.4143)


   

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytridec-4-en-2-yl]octanamide

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxytridec-4-en-2-yl]octanamide

C33H61NO13 (679.4143)


   

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxypentadec-4-en-2-yl]hexanamide

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxypentadec-4-en-2-yl]hexanamide

C33H61NO13 (679.4143)


   

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyundec-4-en-2-yl]decanamide

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyundec-4-en-2-yl]decanamide

C33H61NO13 (679.4143)


   

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyheptadec-4-en-2-yl]butanamide

N-[(E)-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyheptadec-4-en-2-yl]butanamide

C33H61NO13 (679.4143)


   
   
   
   
   
   
   
   
   
   

PE 16:0/12:2;O3

PE 16:0/12:2;O3

C33H62NO11P (679.406)


   
   
   
   
   
   
   
   
   
   
   
   

PS O-20:0/7:2;O2

PS O-20:0/7:2;O2

C33H62NO11P (679.406)


   
   
   
   

PS P-18:0/9:1;O2

PS P-18:0/9:1;O2

C33H62NO11P (679.406)


   
   
   
   
   
   
   
   
   
   
   
   
   

IPC 14:2;O2/13:0

IPC 14:2;O2/13:0

C33H62NO11P (679.406)


   

IPC 15:2;O2/12:0

IPC 15:2;O2/12:0

C33H62NO11P (679.406)


   

IPC 16:2;O2/11:0

IPC 16:2;O2/11:0

C33H62NO11P (679.406)


   

IPC 17:2;O2/10:0

IPC 17:2;O2/10:0

C33H62NO11P (679.406)


   
   

ST 26:5;O8;HexNAc

ST 26:5;O8;HexNAc

C34H49NO13 (679.3204)


   

ST 27:4;O7;HexNAc

ST 27:4;O7;HexNAc

C35H53NO12 (679.3568)


   

ST 28:3;O6;HexNAc

ST 28:3;O6;HexNAc

C36H57NO11 (679.3931)


   

n-(1-oxo-1-{[(8e,10e,16z)-3,15,27-trihydroxy-5-methoxy-14,16-dimethyl-22-thia-2,24-diazatricyclo[18.6.1.0²¹,²⁵]heptacosa-1(27),2,6,8,10,16,20,23,25-nonaen-13-yl]oxy}propan-2-yl)cyclohexanecarboximidic acid

n-(1-oxo-1-{[(8e,10e,16z)-3,15,27-trihydroxy-5-methoxy-14,16-dimethyl-22-thia-2,24-diazatricyclo[18.6.1.0²¹,²⁵]heptacosa-1(27),2,6,8,10,16,20,23,25-nonaen-13-yl]oxy}propan-2-yl)cyclohexanecarboximidic acid

C37H49N3O7S (679.3291)


   

(1s,3r,5r,7s,8e,14e,16e,18e,20e,22s,24r,25s,26r)-22-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,26-trihydroxy-12,13-dimethyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.0⁵,⁷]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid

(1s,3r,5r,7s,8e,14e,16e,18e,20e,22s,24r,25s,26r)-22-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,26-trihydroxy-12,13-dimethyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.0⁵,⁷]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid

C34H49NO13 (679.3204)


   

n-{7-benzyl-11-ethyl-5,8-dihydroxy-3-isopropyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl}-1-[2-(methylamino)-3-phenylpropanoyl]pyrrolidine-2-carboximidic acid

n-{7-benzyl-11-ethyl-5,8-dihydroxy-3-isopropyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl}-1-[2-(methylamino)-3-phenylpropanoyl]pyrrolidine-2-carboximidic acid

C40H49N5O5 (679.3734)


   

(2s)-n-[(3s,4s,7r,10z)-7-benzyl-11-ethyl-5,8-dihydroxy-3-isopropyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-1-[(2s)-2-(methylamino)-3-phenylpropanoyl]pyrrolidine-2-carboximidic acid

(2s)-n-[(3s,4s,7r,10z)-7-benzyl-11-ethyl-5,8-dihydroxy-3-isopropyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-1-[(2s)-2-(methylamino)-3-phenylpropanoyl]pyrrolidine-2-carboximidic acid

C40H49N5O5 (679.3734)


   

22-[(4-amino-3,5-dihydroxy-6-methyloxan-2-yl)oxy]-1,3,26-trihydroxy-12,13-dimethyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.0⁵,⁷]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid

22-[(4-amino-3,5-dihydroxy-6-methyloxan-2-yl)oxy]-1,3,26-trihydroxy-12,13-dimethyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.0⁵,⁷]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid

C34H49NO13 (679.3204)


   

(1r,2s,3s,7s,10r,13r,14s,15r,17r,18r,19r)-8,15,17,18-tetrahydroxy-7-(2-methanesulfinylethyl)-3,19-dimethoxy-2,14,18-trimethyl-10-(2-methylpropyl)-13-propyl-6,12,21-trioxa-9-azabicyclo[15.3.1]henicos-8-ene-5,11-dione

(1r,2s,3s,7s,10r,13r,14s,15r,17r,18r,19r)-8,15,17,18-tetrahydroxy-7-(2-methanesulfinylethyl)-3,19-dimethoxy-2,14,18-trimethyl-10-(2-methylpropyl)-13-propyl-6,12,21-trioxa-9-azabicyclo[15.3.1]henicos-8-ene-5,11-dione

C32H57NO12S (679.3601)


   

(1r,3s,5r,7r,8e,12r,13s,14e,16e,18e,20e,22r,24s,25r,26s)-22-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,26-trihydroxy-12,13-dimethyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.0⁵,⁷]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid

(1r,3s,5r,7r,8e,12r,13s,14e,16e,18e,20e,22r,24s,25r,26s)-22-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-1,3,26-trihydroxy-12,13-dimethyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.0⁵,⁷]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid

C34H49NO13 (679.3204)


   

2-[2-(6-{[(3r,4ar,8s,11r,14s)-3,9,12-trihydroxy-14-methyl-11-(2-methylpropyl)-5,15-dioxo-1h,2h,3h,4h,4ah,7h,8h,11h,14h-pyridazino[3,2-c]1-oxa-4,7,10-triazacyclotridecan-8-yl]-c-hydroxycarbonimidoyl}-5,6-dihydro-4h-pyridazin-1-yl)-2-oxoethyl]heptanoic acid

2-[2-(6-{[(3r,4ar,8s,11r,14s)-3,9,12-trihydroxy-14-methyl-11-(2-methylpropyl)-5,15-dioxo-1h,2h,3h,4h,4ah,7h,8h,11h,14h-pyridazino[3,2-c]1-oxa-4,7,10-triazacyclotridecan-8-yl]-c-hydroxycarbonimidoyl}-5,6-dihydro-4h-pyridazin-1-yl)-2-oxoethyl]heptanoic acid

C31H49N7O10 (679.3541)


   

(2e,4e)-5-[(3s,4s,7s,8r,9r,12s,23r,24s,28s)-7,24-dihydroxy-3,4,8,20,20,22,22-heptamethyl-27-oxo-28-(prop-1-en-2-yl)-21-oxa-1-azaoctacyclo[13.13.1.0²,¹⁴.0³,¹².0⁴,⁹.0¹⁷,²⁵.0¹⁸,²³.0²⁶,²⁹]nonacosa-2(14),15,17(25),18,26(29)-pentaen-8-yl]-2-methylpenta-2,4-dienoic acid

(2e,4e)-5-[(3s,4s,7s,8r,9r,12s,23r,24s,28s)-7,24-dihydroxy-3,4,8,20,20,22,22-heptamethyl-27-oxo-28-(prop-1-en-2-yl)-21-oxa-1-azaoctacyclo[13.13.1.0²,¹⁴.0³,¹².0⁴,⁹.0¹⁷,²⁵.0¹⁸,²³.0²⁶,²⁹]nonacosa-2(14),15,17(25),18,26(29)-pentaen-8-yl]-2-methylpenta-2,4-dienoic acid

C43H53NO6 (679.3873)


   

2-[2-(6-{[(4ar,8s,11r,14s)-9,12-dihydroxy-14-methyl-11-(2-methylpropyl)-5,15-dioxo-1h,2h,3h,4h,4ah,7h,8h,11h,14h-pyridazino[3,2-c]1-oxa-4,7,10-triazacyclotridecan-8-yl]-c-hydroxycarbonimidoyl}-5,6-dihydro-4h-pyridazin-1-yl)-2-oxoethyl]-6-hydroxyheptanoic acid

2-[2-(6-{[(4ar,8s,11r,14s)-9,12-dihydroxy-14-methyl-11-(2-methylpropyl)-5,15-dioxo-1h,2h,3h,4h,4ah,7h,8h,11h,14h-pyridazino[3,2-c]1-oxa-4,7,10-triazacyclotridecan-8-yl]-c-hydroxycarbonimidoyl}-5,6-dihydro-4h-pyridazin-1-yl)-2-oxoethyl]-6-hydroxyheptanoic acid

C31H49N7O10 (679.3541)